Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Immovilli

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
European Journal of Neurology|March 29, 2024
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)Irene Schiavetti, Alessio Signori, Angela Albanese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapiesIrene Schiavetti, Cinzia Cordioli, Maria Laura Stromillo, et al.
Annals of Clinical and Translational Neurology|July 9, 2021
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and FranceMaria Pia Sormani, Marco Salvetti, Pierre Labauge, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Abuse in individuals with multiple sclerosis: the SocialMS Italian studyMarta Ponzano, Alessio Signori, Irene Schiavetti, et al.
Neuroepidemiology|May 9, 2021
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, ItalyElisa Baldin, Corrado Zenesini, Ippazio Cosimo Antonazzo, et al.
Multiple Sclerosis and Related Disorders|June 8, 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple SclerosisMarta Ponzano, Irene Schiavetti, Francesca Bovis, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Irene Schiavetti, Roberto Bergamaschi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2023
Sars-CoV2 infection in pregnant women with multiple sclerosisMaria Grazia Aprea, Irene Schiavetti, Emilio Portaccio, et al.
JAMA Network Open|November 3, 2025
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MSShalom Haggiag, Luca Prosperini, Massimo Filippi, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
European Journal of Neurology|March 29, 2024
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)Irene Schiavetti, Alessio Signori, Angela Albanese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapiesIrene Schiavetti, Cinzia Cordioli, Maria Laura Stromillo, et al.
Annals of Clinical and Translational Neurology|July 9, 2021
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and FranceMaria Pia Sormani, Marco Salvetti, Pierre Labauge, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Abuse in individuals with multiple sclerosis: the SocialMS Italian studyMarta Ponzano, Alessio Signori, Irene Schiavetti, et al.
Neuroepidemiology|May 9, 2021
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, ItalyElisa Baldin, Corrado Zenesini, Ippazio Cosimo Antonazzo, et al.
Multiple Sclerosis and Related Disorders|June 8, 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple SclerosisMarta Ponzano, Irene Schiavetti, Francesca Bovis, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Irene Schiavetti, Roberto Bergamaschi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2023
Sars-CoV2 infection in pregnant women with multiple sclerosisMaria Grazia Aprea, Irene Schiavetti, Emilio Portaccio, et al.
JAMA Network Open|November 3, 2025
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MSShalom Haggiag, Luca Prosperini, Massimo Filippi, et al.
Pageof 5